atr-101
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2013 (NCT01898715)
Timeline
Indications
Mechanism of action
inhibitor - ACAA2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- atr-101
- atr-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03053271 | Phase 2 | Feb 16, 2017 | Medical College of Wisconsin, Millendo Therapeutics, Inc. |
| NCT02804178 | Phase 2 | May 1, 2016 | Millendo Therapeutics, Inc. |
| NCT01898715 | Phase 1 | Jul 1, 2013 | Millendo Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Millendo Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2013 |
| Medical College of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1